MSFS
GILD icon

Main Street Financial Solutions’s Gilead Sciences GILD Stock Holding History

Main Street Financial Solutions’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.09K Buy
+500
New +$65.9K ﹤0.01% 613

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Main Street Financial Solutions's GILD Position: Q2 2026 in Review

Main Street Financial Solutions reduced its Gilead Sciences (GILD) stake by 6.8% in Q2 2026, selling an estimated $26.5K and leaving 2,746 shares worth $347K. The position accounts for 0.02% of the portfolio, ranked #444.

Main Street Financial Solutions first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. The position peaked at $411K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Main Street Financial Solutions held 2,746 shares of Gilead Sciences worth $347K as of Q2 2026.
  • Main Street Financial Solutions sold 201 Gilead Sciences shares in Q2 2026, an estimated $26.5K.
  • Gilead Sciences made up 0.02% of Main Street Financial Solutions's portfolio in Q2 2026, its #444 holding.
  • Main Street Financial Solutions first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • Main Street Financial Solutions's Gilead Sciences position peaked at $411K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Main Street Financial Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.